Short Interest in Sartorius (OTCMKTS:SARTF) Drops By 76.3%

Posted by on Jun 11th, 2026

Sartorius (OTCMKTS:SARTF – Get Free Report) was the recipient of a significant decline in short interest in May. As of May 29th, there was short interest totaling 579 shares, a decline of 76.3% from the May 14th total of 2,447 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average trading volume of 53 shares, the days-to-cover ratio is currently 10.9 days.

Sartorius Price Performance

Shares of SARTF stock remained flat at $217.65 on Thursday. The company has a debt-to-equity ratio of 0.89, a quick ratio of 0.49 and a current ratio of 0.95. The stock’s 50 day moving average is $218.40 and its 200-day moving average is $221.14. The company has a market capitalization of $7.45 billion, a PE ratio of 101.23 and a beta of 0.98. Sartorius has a 1 year low of $181.58 and a 1 year high of $227.00.

About Sartorius

(Get Free Report)

Sartorius AG, trading in the U.S. over the counter under the symbol SARTF, is a Germany-based provider of laboratory and bioprocessing equipment for the pharmaceutical, biotechnology and research industries. The company is organized into two core divisions: Bioprocess Solutions, which focuses on single-use consumables, filtration technologies and upstream and downstream processing systems; and Lab Products & Services, which supplies laboratory instruments, consumables and services, including balances, pipettes, cell counting systems and water purification units.

The Bioprocess Solutions segment serves customers engaged in the development and manufacture of biopharmaceuticals, vaccines and advanced therapies.

Read More

Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.